| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | CHIEF FINANCIAL OFFICER | Common Stock | 53.5K | $1.82M | $34.02 | Jul 16, 2024 | Direct |
| PTC THERAPEUTICS, INC. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 47.5K | $1.28M | $27.05 | Feb 15, 2024 | Direct |
| CASSAVA SCIENCES INC | Director | Stock Option (Right to Buy) | 10K | $169K | $16.87 | May 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | Jul 16, 2024 | 1 | -$77.2K | 4 | Jul 18, 2024 | CHIEF FINANCIAL OFFICER |
| SAVA | CASSAVA SCIENCES INC | May 9, 2024 | 1 | $0 | 4 | May 13, 2024 | Director |
| PTCT | PTC THERAPEUTICS, INC. | Feb 15, 2024 | 3 | $0 | 4 | Feb 16, 2024 | CHIEF FINANCIAL OFFICER |
| PTCT | PTC THERAPEUTICS, INC. | Dec 12, 2023 | 1 | $199K | 4 | Dec 14, 2023 | CHIEF FINANCIAL OFFICER |
| SAVA | CASSAVA SCIENCES INC | Dec 6, 2023 | 1 | $0 | 4 | Dec 7, 2023 | Director |
| SAVA | CASSAVA SCIENCES INC | Dec 6, 2023 | 0 | $0 | 3 | Dec 7, 2023 | Director |
| PTCT | PTC THERAPEUTICS, INC. | Jul 13, 2023 | 2 | $0 | 4 | Jul 17, 2023 | CHIEF FINANCIAL OFFICER |
| PTCT | PTC THERAPEUTICS, INC. | Jul 13, 2023 | 0 | $0 | 3 | Jul 17, 2023 | CHIEF FINANCIAL OFFICER |